Julie Shepard
5 Papers
48 Citations
Julie Shepard is an academic researcher. The author has contributed to research in topics: Varicella vaccine & Vaccination. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers.
TL;DR: Concomitant administration of MenACWY-CRM with MMRV vaccinations at 12 months was well-tolerated, without safety concerns, and all criteria for non-inferiority were met, supporting the use of a 2-dose regimen of MenATM in this age group.
32
Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
Mark M. Blatter,Nicola P. Klein,Julie Shepard,Michael Leonardi,Steven Shapiro,Martin Schear,Maurice A. Mufson,Judith M. Martin,Meera Varman,Stanley E. Grogg,Arnold London,Pierre Cambron,Martine Douha,Ouzama Nicholson,Christopher da Costa,Bruce L. Innis +15 more
TL;DR: The vaccines showed acceptable reactogenicity/safety when coadministered with HAV and PCV7, and noninferiority of both GSK+4C and GSK-20C vaccines versus Merck-20 C was demonstrated for seroresponse rates to measles, mumps and rubella viruses.
24
•Journal Article
A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration
Huang Yhu-Chering,Dae Sun Jo,Chun Soo Kim,Hwang Min Kim,Kwang Nam Kim,Kyung Hyo Kim,Yun Kyung Kim,Nicola P. Klein,Sang-Hyuk Ma,Christopher Peltier,Shelly Senders,Julie Shepard,Tsung Zu Wu,Shu Jen Yeh,Edward Zissman,Paul Gillard,Michael Povey,Remon Abu-Elyazeed,Ouzama Henry,Mmr Study Grp,Chiu Nan-Chang,Robert Clifford,Huang Li-Min +22 more
TL;DR: The immunogenicity and safety profiles of MMR-RIT administered with or without co-administered with DTaP-IPV and VV were similar to those of MMR II.
13
Immunogenicity and Safety of a 3- and 4-dose Vaccination Series of a Meningococcal ACWY Conjugate Vaccine in Infants: Results of a Phase 3b, Randomized, Open-label Trial
TL;DR: After completion of either MenACWY-CRM vaccination series, most subjects achieved seroprotective titers against serog groups ACWY, with the 3-dose series being noninferior to the 4-doseseries for serogroups CWY, and no interference with immune responses against PCV13 serotypes was observed.
11
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
Remon Abu-Elyazeed,Nicola P. Klein,Leentje Moerman,Michael Povey,Anthony Pruitt,Shelly Senders,Peter E. Silas,Dan Bi,Armando Acevedo,Rogelio Amisola,Luke Anschutz,Regine Bataille,James D. Campbell,Matthew Cornish,Joseph B. Domachowske,John A. Fling,Earl Franklin,Joshua Fuller,Alvin Gabrielsen,Alan Garscadden,Giancarlo Guido,James Hedrick,David J. Hurley,Donald Hurley,William Johnston,Aarti Kulshrestha,Michael Leonardi,Martin Levinson,Sean Livingston,Gary S. Marshall,Paola Pirrotta,Walter Rok,Stephen Russell,Martin Schear,Julie Shepard,Laurent Sigg,Tina Singh,Mary Tipton,Ana Ugarte,Paul Wisman,Edward Zissman +40 more
TL;DR: Routine pediatric vaccines co- administered with Liq PCV-free HRV showed non-inferior immune responses and similar safety profiles to those following co-administration with Lyo HRV, and co-primary objectives were demonstrated.
4